Current evidence linking gut microbiota metabolites to diabetic kidney disease is primarily correlational and derived from cross-sectional studies, with limited prospective data or interventional trials to establish causation or clinical efficacy of targeted interventions.

Bad bacteria in the gut break down protein from food into toxic chemicals that leak into the blood because the gut lining becomes damaged. These toxins travel to the kidneys, where they trigger oxidative stress and inflammation, damage kidney cells, and cause scarring. At the same time, good bacteria that break down fiber produce protective chemicals that fix the gut lining and calm inflammation, but these are reduced in disease. The imbalance between harmful and protective bacterial products directly worsens kidney damage in diabetes.